Literature DB >> 12566089

Antioxidants significantly affect the formation of different classes of isoprostanes and neuroprostanes in rat cerebral synaptosomes.

Thomas J Montine1, Kathleen S Montine, Erin E Reich, Erin S Terry, Ned A Porter, Jason D Morrow.   

Abstract

Lipid peroxidation has been implicated in the pathogenesis of a number of diseases, including neurodegenerative disorders. Evidence that antioxidants can affect the clinical course of neurodegenerative diseases is limited. In the present study, we examined the ability of five common antioxidants or antioxidant combinations, alpha-tocopherol, gamma-tocopherol, ascorbic acid, GSH ethyl ester, and a combination of ascorbate and alpha-tocopherol, to modulate lipid peroxidation in peroxidizing rat cerebral synaptosomes, a well-characterized model of oxidant injury. In these studies, we quantified isoprostanes (IsoPs) derived from arachidonic acid as an index of whole tissue oxidation and neuroprostanes (NeuroPs) formed from docosahexaenoic acid as a marker of selective neuronal peroxidation. We report that these various antioxidants displayed markedly different capacities to inhibit IsoP and NeuroP formation with the most potent effects on IsoPs observed for ascorbate, GSH ethyl ester, and the alpha-tocopherol-ascorbate combination. alpha-Tocopherol was slightly less potent and gamma-tocopherol significantly less effective. The concentration-response relationships were significantly different for NeuroP formation with the antioxidants being significantly less potent than for IsoP generation. In particular, alpha-tocopherol did not inhibit NeuroP formation at concentrations up to 100 microM. We also determined that tocopherols, in particular alpha-tocopherol, act in vitro as reducing agents to convert IsoP and NeuroP endoperoxides to reduced F-ring compounds, a finding we have observed previously in vivo in brain. These studies are of importance because they have further defined the role of antioxidants to modulate the formation of lipid peroxidation products in peroxidizing brain tissue. In addition, they suggest that alpha-tocopherol may not be a particularly effective agent to inhibit oxidant stress in the terminal compartment of neurons in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12566089     DOI: 10.1016/s0006-2952(02)01607-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  12 in total

1.  Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration.

Authors:  Erik S Musiek; Rebecca S Breeding; Ginger L Milne; Giuseppe Zanoni; Jason D Morrow; Bethann McLaughlin
Journal:  J Neurochem       Date:  2006-04-21       Impact factor: 5.372

Review 2.  Human biochemistry of the isoprostane pathway.

Authors:  Ginger L Milne; Huiyong Yin; Jason D Morrow
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

Review 3.  The isoprostanes--25 years later.

Authors:  Ginger L Milne; Qi Dai; L Jackson Roberts
Journal:  Biochim Biophys Acta       Date:  2014-10-30

Review 4.  Recent advances in the biochemistry and clinical relevance of the isoprostane pathway.

Authors:  Erik S Musiek; Huiyong Yin; Ginger L Milne; Jason D Morrow
Journal:  Lipids       Date:  2005-10       Impact factor: 1.880

Review 5.  Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity.

Authors:  Erik S Musiek; Ginger L Milne; BethAnn McLaughlin; Jason D Morrow
Journal:  Brain Pathol       Date:  2005-04       Impact factor: 6.508

6.  Isoprostanes.

Authors:  L Jackson Roberts; Ginger L Milne
Journal:  J Lipid Res       Date:  2008-10-28       Impact factor: 5.922

7.  Lipid peroxidative damage on malathion exposure in rats.

Authors:  Jucéla J Fortunato; Fabiano R Agostinho; Gislaine Z Réus; Fabrícia C Petronilho; Felipe Dal-Pizzol; João Quevedo
Journal:  Neurotox Res       Date:  2006-01       Impact factor: 3.911

Review 8.  Electrophilic cyclopentenone isoprostanes in neurodegeneration.

Authors:  Erik S Musiek; Bethann McLaughlin; Jason D Morrow
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

Review 9.  Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation.

Authors:  Jochen Bauer; Anne Ripperger; Stefan Frantz; Süleyman Ergün; Edzard Schwedhelm; Ralf A Benndorf
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

Review 10.  Application of medical and analytical methods in Lyme borreliosis monitoring.

Authors:  Magdalena Ligor; Paweł Olszowy; Bogusław Buszewski
Journal:  Anal Bioanal Chem       Date:  2011-10-21       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.